SeoulMarkets · tag
dart
40 stories tagged “dart”, each from official Korean data with its source and timestamp.
Korean business segment reporting, by company size: the biggest disclose eight, the smallest disclose one
Half of 737 Korean listed companies report a single business segment. Among companies above $10bn in market value only 23% do — and their median is eight. Segment disclosure is not in the accounts tape; it is in the annual report text.
10 More Korean Rights Issues: One Diluted 17.3%, Another 61.6%
A fresh batch of filings, late August through mid-September: the largest raise (Samsung FN REIT, ₩97.7bn) diluted shareholders 17.3%. The second-largest (Heng Sheng Holding Group, ₩60.0bn) diluted them 61.6%. Not advice.
A 2021 Drama Licensing Deal Was Kept Secret for Five Years. The Embargo Just Ended.
Samhwa Networks signed a $5.6 million global streaming license for its drama Now, Showtime! in 2021 and was allowed to withhold the amount. The filing disclosing it, five years later, states why: the embargo period ran out.
A Coupang Robotics Contract Shrank by 40% — After the Work Was Done
CMES Robotics disclosed a ₩1.19 billion Coupang warehouse-automation contract as 17.2% of revenue. Its amendment, filed after the contract ended, revises it down to ₩713 million — 10.34% — the amount actually collected.
K3I's Buyer Has ₩5.8 Billion in Assets. It's Paying ₩21 Billion for Control.
J's Commerce, formed in 2018, is buying a 39.96% stake in K3I from the founder's family for ₩21 billion. Its own filed balance sheet shows ₩5.836 billion in total assets — far below the purchase price.
Namhwa Construction Amended a ₩7.68 Billion Contract — Only the Timeline Changed
Namhwa Construction's supply contract with Daegwang Community Credit Cooperative, worth 13.56% of revenue, was amended on 23 September. The filing states only the contract period changed — the amount did not.
Spear Won't Name Its Aerospace Customer. The Filing Still Gives Up 12%.
Spear disclosed an ₩11.58 billion special-alloy contract worth 12.1% of revenue. The counterparty is withheld, described only as a 'US global aerospace launch company' — but the amount and ratio are not.
Two Korean Companies Filed Share Cancellations the Same Day. One Retires Nearly 10% of Its Stock.
Intem and KTis both filed board-approved share cancellation decisions on 23 September. Intem is retiring 4.74% of its shares; KTis is retiring 9.76% — more than double the ratio, from already-acquired treasury stock in both cases.
Stretch the window from three years to five and Korea's unbroken-profit share falls from 45.3% to 37.7%
Of 2,049 Korean listed companies that filed a net profit in all five years from 2021 to 2025, 772 were profitable in every one. The same test over 2023–2025 passes 1,072 of 2,368 — the count moves with the window.
Hyundai Rotem's Taiwan Rail Contract Is 5.9% of Last Year's Revenue
A ₩344.5 billion supply contract with Taiwan's Taoyuan Department of Rapid Transit Systems runs through October 2034 — eight years, filed the same day as two other same-industry disclosures.
11.7% of Japanese listed filers reported a net loss. In Korea the figure is 38.2%
We now hold filed annual accounts for 3,672 Japanese listed companies alongside 2,709 Korean ones. On the most recent filing each side, the median Japanese filer earned an 8.0% return on equity; the median Korean filer earned 2.6%.
49.0% on KOSPI, 31.9% on KOSDAQ — and on KONEX we cannot count at all
Split Korea's five-year profit streaks by listing board and the market-wide 37.7% comes apart. KONEX gets no figure: only 6 of its 107 companies filed annual accounts in all five years.
SK Biopharmaceuticals Signed a 9% Supply Contract — With Its Own Subsidiary
The ₩63.3 billion deal names SK Life Science, Inc. as the counterparty, and the filing states the relationship: SK Biopharmaceuticals' own subsidiary. The filing ties it to XCOPRI, the company's US-marketed epilepsy drug.
A Korean Controlling Shareholder Crossed 51% in One Filing
Hantop's largest shareholder reported a 9.16-point jump to 51.56% on 8 September — one filing combining a related party's private-placement share purchase with a change to pledged loan collateral.
A Korean REIT Issued Two Convertible Bonds the Same Day. Together They're 8.13% Dilution.
Koramco Life Infra REIT's board approved two private convertible bonds on 21 September — same conversion price, same coupon, same maturity date — worth a combined 34 billion won and 8,308,894 potential new shares.
Cellid Raised 10 Billion Won by Diluting Shares 16 Percent
A single third-party placement filed today adds 4.8 million new Cellid shares to a base of 29.5 million — 16.26% dilution, with the company's own filing marking 9.999 billion of the roughly 10 billion won raised as general operating funds.
Four Korean Dilution Filings Landed in Three Weeks. One Tops 100 Percent.
Korea Advanced Materials issued two same-day, same-price convertible bonds worth a combined 20.62% dilution — the fourth of four unrelated dilution filings we checked from early September to today, ranging from 8% to 164%.
More Than Half of Korea's Material Filings Are Corrections of Earlier Ones
Of 816 material disclosures Korean listed companies filed in 28 days, 430 — 52.7% — are re-filings marked as corrections. Convertible bonds 72%, capital raises 65%, supply contracts 60%. Not advice.
One Korean Convertible Bond Is Worth 164% of the Company's Shares. A Second, Filed a Day Later, Is 13%.
THE CODI's board approved a 30 billion won convertible bond on 7 September that would create more shares than the company has outstanding — 163.75% dilution by its own figure — then a smaller bond the next day.
POSCO Holdings' Stake in Two Units Landed Right at the 50% Line, Same Day
Two 5%-ownership disclosures filed the same day show POSCO Holdings' stake falling to 50.01% in POSCO International and exactly 50% in POSCO DX — both crossing more than 15 percentage points down in a single filing.
A Company Paid a 9.6% Premium to Cancel a Convertible Bond It Had Sold Three Months Earlier
Emgen Solution sold a private convertible bond in June 2026. In September it bought the whole issue back for 9.6% over face value -- canceling 8.3% worth of potential dilution, 32 months before the bond was due.
One broker's target price fell 75 percent overnight. It was a stock split, not a downgrade.
Of 53 target-price revisions filed on September 21, one showed a 75% overnight cut. The company's shares had been split 4-for-1 five weeks earlier — the number was arithmetic, not a bearish call.
Samsung C&T's 1.83 Trillion Won Project Is a Construction Selection, Not Yet a Contract
Samsung C&T disclosed being chosen to build a 1.8275 trillion won Seoul redevelopment project -- 4.49% of its FY2025 revenue. The filing itself says the amount can still change and the actual contract has not been signed.
Seohee Construction's New Contract Is 29% of Last Year's Revenue. It Doesn't Start for 21 Months.
A single apartment contract filed today equals 28.93% of Seohee Construction's most recent revenue. Construction starts in June 2027 — and this exact contract type has fallen through for the company before.
Four Korean firms filed identical 'rumor unconfirmed' disclosures the same day. One stock fell, one rose.
Four Korean firms filed identical 'rumor unconfirmed' disclosures on September 18 — zero other days in our 17-day scan had any. Press reports say two of them moved in opposite directions.
One Korean private placement diluted shares by 80 percent. Another, by 106 percent.
NC& and Satoshi Holdings each filed third-party share placements this month. NC&'s new shares equal 79.7% of its prior count; Satoshi's new shares exceed its prior count outright, at 105.9%.
Three Korean companies announced buybacks on the same day. Only one will retire the shares.
Exem, Shinhung, and Handsome Corporation filed buybacks on September 18. Handsome's plan is 7-10x larger and the only one that also commits to cancelling the shares.
Zero Korean companies changed CEO or owner for 17 straight trading days. Then seven did, in one.
DART recorded zero CEO-change and control-change disclosures on 17 straight scanned days. On September 18, three companies replaced their CEO and four filed ownership-change corrections.
10 Korean-listed companies filed delisting-risk disclosures on one day
DART recorded delisting-risk disclosures from ten separately listed companies on September 18 — zero on any other day this week. We could not confirm why they clustered on this date.
We graded 2,415 Korean listed companies on their own filings. The national power utility scored near the bottom.
SMarkets Grade, our balance-sheet score built from DART filings, places Korea Electric Power at SM8 — second-weakest of nine tiers — on 4.17x debt-to-equity and a 0.46 current ratio. Not a credit rating, not advice.
A 75-point stake vanished — and the filing didn't name who took over
Tongyang Life's Chinese owner reported selling its entire stake in one filing, the largest exit in our ledger of Korean ownership disclosures. Of the nine biggest full sell-outs we found, only three say a controlling shareholder changed.
Samsung Life's rumor answer: not confirmed, not denied
A news report said Samsung Fire and Samsung Life were buying large UK and US insurers. Samsung Life's own DART filing says only that it is reviewing investment targets — nothing decided. It has until October 2 to say more.
96% of Korean firms pay men more
A census of 2,282 Korean listed companies' own half-year filings: the median company pays men 35.9% more than women. 96.0% pay men more by 5% or more. Only 1.4% pay women more.
Korea's listed firms: median tenure is 6.2 years
A census of 2,839 Korean listed companies' own annual filings: the median company's staff has stayed 6.2 years on average. 1 in 8 companies average under 3 years — and a smaller 1 in 17 average 15 years or more.
35 Korean capital raises ranked 3 ways — size never predicted the outcome
This week we ranked 35 Korean capital-raising filings three ways — buybacks, rights issues, convertible bonds. In every single one, the size of the deal did not predict what it meant for existing shareholders.
KG Mobility's convertible bond dilutes shares 22%
Five Korean convertible bonds filed this week all pay 0% surface interest — the option to convert is the entire return. Potential dilution on conversion ranges from 1.0% to 22.0%, and it isn't the biggest raise that dilutes least.
Meritz Securities: top pay, 2.18x gender gap
CEOScore reported nine Korean firms with H1 2026 average pay above ₩100m. We re-pulled the same DART filings and split them by gender — every one has a gap, from 1.31x to 2.18x.
Celltrion's biggest buyback won't cancel a share
Celltrion's ₩100.0bn buyback dwarfs eight others filed with Korea's regulator this week — and carries no cancellation clause. The three firms that do promise to cancel are the smallest on the list.
Samsung Biologics raised 300x more, diluted 11x less
Samsung Biologics' ₩3.00tn rights issue diluted shareholders 4.7%. PhionX raised 300 times less — and diluted 53.8%, eleven times more. Twenty-one filings this week show size doesn't predict dilution.
Why Korean market data has a 1-business-day legal lag — and one exception
The data this site publishes settles on a one-business-day lag — not by editorial choice but because that is what the redistributable sources release. One exception changes what is possible.